Initiator Pharma A/S
INIT
Rank in Stocks
#27098
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to... Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.24486274
Last synced: 2026-11-09
Market Cap
$16.76M
Change (1 day)
11.10%
Change (1 year)
-18.45%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Initiator Pharma A/S (INIT)
Category
Healthcare
EPS for Initiator Pharma A/S (INIT)
EPS as of June 2026 TTM: $-0.06
According to Initiator Pharma A/S's latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $-0.03.
EPS history for Initiator Pharma A/S from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | 49.25% |
| 2025 | $-0.04 | 12.46% |
| 2024 | $-0.03 | 32,000.00% |
| 2023 | 0.00 | -99.91% |
| 2022 | $-0.12 | 25.38% |
| 2021 | $-0.09 | 74.86% |
| 2020 | $-0.05 | 9.37% |
| 2019 | $-0.05 | -21.82% |
| 2018 | $-0.06 | -60.72% |
| 2017 | $-0.16 | 1,283.19% |
| 2016 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -26,331.16% |
US
|
|
| $-7.07 | 11,742.55% |
US
|
|
| $-5.29 | 8,760.97% |
AU
|
|
| $12.88 | -21,674.71% |
BE
|
|
| $21.56 | -36,213.90% |
NL
|
Questions about Initiator Pharma A/S's earnings per share (EPS)
What is Initiator Pharma A/S's earnings per share (EPS)?
Initiator Pharma A/S's earnings per share (EPS) over the last twelve months is $-0.06, as of Jun 2026.
What was Initiator Pharma A/S's earnings per share (EPS) in 2025?
In 2025, Initiator Pharma A/S's earnings per share (EPS) was $-0.04, compared with $-0.03 in 2024.
How has Initiator Pharma A/S's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Initiator Pharma A/S's earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2022 ($-0.12).
How does Initiator Pharma A/S's earnings per share (EPS) compare with similar companies?
Initiator Pharma A/S's earnings per share (EPS) ($-0.06) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.